Heart Test Laboratories
HSCS
7 hedge funds and large institutions have $372K invested in Heart Test Laboratories in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 0 closing their positions.
365% more capital invested
Capital invested by funds: $80K → $372K (+$292K)
75% more funds holding
Funds holding: 4 → 7 (+3)
0.05% more ownership
Funds ownership: 0.01% → 0.05% (+0.05%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OLVIG
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
|
+$214K |
| 2 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$202K |
| 3 |
TWM
Tradition Wealth Management
Edina,
Minnesota
|
+$62.6K |
| 4 |
Renaissance Technologies
New York
|
+$11.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OLVIG
1
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| $136K | +$214K | +1,368 | +547% |
|
|
AWM
2
AE Wealth Management
Topeka,
Kansas
| $130K | +$202K | +1,292 | +517% |
|
|
CD
3
Chapin Davis
Baltimore,
Maryland
| $46.2K | +$86.1K | +550 | New |
|
|
TWM
4
Tradition Wealth Management
Edina,
Minnesota
| $34K | +$62.6K | +400 | New |
|
|
5
Renaissance Technologies
New York
| $19K | +$11.4K | +73 | +47% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $6K | +$11K | +70 | New |
|
7
UBS Group
Zurich,
Switzerland
| $1.64K | +$313 | +2 | +11% |
|
8
Wells Fargo
San Francisco,
California
| $9 | – | – | – |
|
HSCS Hedge Fund Activity: Q4 2022 in Review
7 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q4 2022, worth a combined $372K — up 365% from $80K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new HSCS positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Oliver Lagore Vanvalin Investment Group, adding an estimated $214K.
- 7 institutional investors held Heart Test Laboratories (HSCS) as of Q4 2022, up from 4 in Q3 2022.
- Funds reported $372K of Heart Test Laboratories stock for Q4 2022, up 365% quarter-over-quarter.
- 3 funds opened new Heart Test Laboratories positions in Q4 2022 and 0 closed out, a net change of +3 holders.
- The largest Heart Test Laboratories buyer in Q4 2022 was Oliver Lagore Vanvalin Investment Group, an estimated $214K added.
Based on aggregated 13F filings for Q4 2022.